Gaois

Search direction

Search mode

Filter results

Collections

6 results in 1 document

  1. #3221266

    Déanfar meastóireacht ar dhoiciméadacht PMF laistigh den iarratas ar údarú margaíochta láraithe.

    The PMF documentation shall be evaluated within the centralised marketing authorisation application.

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

  2. #3221270

    Beidh feidhm ag táille EUR 20400 maidir le hiarratas ar athbhreithniú agus athdheimhniú bliantúil ar PMF a bhféadfaidh aon athrú de bhun Rialachán (CE) Uimh. 1234/2008 a chuirtear isteach go comhuaineach leis an iarratas ar athdheimhniú bliantúil ar PMF a bheith san áireamh leis.

    A fee of EUR 20400 shall apply to an application for review and annual re-certification of a PMF which may include any variation pursuant to Regulation (EC) No 1234/2008 submitted simultaneously with the application for a PMF annual re-certification.

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

  3. #3221262

    Deimhniú um chomhlíonadh reachtaíocht an Aontais le haghaidh máistirchomhad plasma (PMF) i gcomhréir le Cuid III d’Iarscríbhinn I a ghabhann le Treoir 2001/83/CE

    Certification of compliance with Union legislation for a plasma master file (PMF) in accordance with Part III of Annex I to Directive 2001/83/EC

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

  4. #3221263

    Beidh feidhm ag táille EUR 69000 maidir le hiarratas ar athbhreithniú ar PMF agus a dheimhniú tosaigh de bhun Chuid III, pointe 1.1, d’Iarscríbhinn I a ghabhann le Treoir 2001/83/CE.

    A fee of EUR 69000 shall apply to an application for review of a PMF and its initial certification pursuant to Part III, point 1.1, of Annex I to Directive 2001/83/EC.

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

  5. #3221267

    Beidh feidhm ag táille EUR 12800 maidir le hiarratas ar athbhreithniú agus deimhniú ar mhórathrú de chineál II ar PMF de bhun Rialachán (CE) Uimh. 1234/2008.

    A fee of EUR 12800 shall apply to an application for review and certification of a major variation of type II to the PMF pursuant to Regulation (EC) No 1234/2008.

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95

  6. #3221265

    Beidh feidhm ag muirear EUR 6900 maidir le deimhniú PMF tosaigh a eisiúint i gcás ina gcuirtear isteach go comhuaineach é le hiarratas ar údarú margaíochta le haghaidh táirge íocshláinte faoin nós imeachta láraithe.

    A charge of EUR 6900 shall apply to the issuing of an initial PMF certification where it is submitted simultaneously with an application for a marketing authorisation for a medicinal product under the centralised procedure.

    Regulation (EU) 2024/568 of the European Parliament and of the Council of 7 February 2024 on fees and charges payable to the European Medicines Agency, amending Regulations (EU) 2017/745 and (EU) 2022/123 of the European Parliament and of the Council and repealing Regulation (EU) No 658/2014 of the European Parliament and of the Council and Council Regulation (EC) No 297/95